A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

AstraZeneca and Merck & Co have cemented ... are already on Lynparza’s list of approved indications. Use in ovarian and breast cancer has already put the drug firmly on course to top the $1 ...

Merck's most important product is Keytruda, a cancer drug that has won approval to treat ... Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our ...

We recently compiled a list of the 9 Best Dow Stocks to Buy According to Analysts. In this article, we are going to take a ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired ... 2024 Healthcare & Pharmaceuticalscategory Americans hungry for weight-loss drugs grapple with supply and insurance hurdles November ...

Wells Fargo analyst Mohit Bansal lowered the firm’s price target on Merck (MRK) to $110 from $125 and keeps an Equal Weight rating on the ...

Deutsche Bank lowered the firm’s price target on Merck (MRK) to $140 from $145 and keeps a Buy rating on the shares following the Q3 ...

The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...